Top Markets
#1 Helium Helium +108.34%
#2 MowCat MowCat +101.34%
#3 Seeker Seeker +77.99%
#4 Pons Pons +47.43%
#5 AI XOVIA AI XOVIA +45.07%
#6 UnifAI Network UnifAI Network +33.66%
#7 Bounce Bounce +30.38%
#8 Tensor Tensor +23.04%
#9 Zylo Ecosystem Zylo Ecosystem +21.26%
#10 TENDIES TENDIES +20.44%
Coin of the day
Helium Helium
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Rankning i aktier #11443
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Aktiekurs
$8.74
Senast synkroniserad: 2026-08-28
Marknadsvärde
$699.74M
Förändring (1 dag)
-4.85%
Förändring (1 år)
-2.29%
Land
US
Handel BridgeBio Oncology Therapeutics Inc. (BBOT)

Kategori

Healthcare
Utdelningsavkastning för BridgeBio Oncology Therapeutics Inc. (BBOT)
Utdelningsavkastningen (TTM) för BridgeBio Oncology Therapeutics Inc. (aktiesymbol: BBOT) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för BridgeBio Oncology Therapeutics Inc. (BBOT) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
Företag Utdelningsavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH